1. Corporate Officers - L
2. Leggett Thomas

Insider Trading History of Leggett Thomas

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Leggett Thomas since 2020. This trader's CIK number is 1774690. At the time of last reporting, Leggett Thomas was the Chief Financial Officer of Stoke Therapeutics, Inc.. (stock ticker symbol STOK). Also see all insider trading activities at Stoke Therapeutics, Inc..

Note that in the past Leggett Thomas also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stoke Therapeutics, Inc. (STOK) by Leggett Thomas

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	STOK	0	$0	4,578	$148,755	14,750	$0

Yearly summary of insider trading at Black Diamond Therapeutics, Inc. (BDTX) by Leggett Thomas

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	BDTX	0	$0	3,000	$101,820	3,000	$32,580
2020	BDTX	0	$0	12,000	$393,450	12,000	$130,320

Insider trading activities at 2 companies by Leggett Thomas:

1. Stoke Therapeutics, Inc. (STOK)

2. Black Diamond Therapeutics, Inc. (BDTX)

Table 1. Insider trading of Stoke Therapeutics, Inc. (STOK) by Leggett Thomas

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-03-17	STOK	Sale	2,196	33.06	72,593
2026-03-18	STOK	Sale	2,382	31.97	76,162
2026-03-15	STOK	Option Ex	14,750	.00	0

Table 2. Insider trading of Black Diamond Therapeutics, Inc. (BDTX) by Leggett Thomas

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-01-08	BDTX	Option Ex	3,000	10.86	32,580
2021-01-08	BDTX	Sale	3,000	33.94	101,820
2020-12-08	BDTX	Option Ex	3,000	10.86	32,580
2020-12-08	BDTX	Sale	3,000	33.66	100,983
2020-11-09	BDTX	Sale	3,000	32.96	98,892
2020-11-09	BDTX	Option Ex	3,000	10.86	32,580
2020-10-08	BDTX	Option Ex	3,000	10.86	32,580
2020-10-08	BDTX	Sale	3,000	33.52	100,575
2020-09-14	BDTX	Option Ex	3,000	10.86	32,580
2020-09-14	BDTX	Sale	3,000	31.00	93,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leggett Thomas (Chief Financial Officer of Stoke Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month